SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-053836
Filing Date
2020-10-05
Accepted
2020-10-05 17:58:37
Documents
2
Period of Report
2020-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1638
2 POA DOCUMENT poa.txt EX-24.3_940479 3583
  Complete submission text file 0001209191-20-053836.txt   6613
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Issuer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 TOYOTA PLAZA, 7TH FLOOR MEMPHIS TN 38103
Business Address
Wills Robert James (Reporting) CIK: 0001634189 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38899 | Film No.: 201224814